肝脏储备功能临床应用研究(4)
[17]Biggins SW,KimWR,Terrault NA,et al.Evidence-Based Incorporation of Serum Sodium Concentration Into MELD[J].Gastroenterology,2006,130(6):1652-1660.
[18]張辉,贾雷,姚士伟,等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析[J].临床肝胆病杂志,2018,34(9):142-147.
[19]Wang J,Wang AJ,Li BM,et al.MELD-Na:Effective in Predicting Rebleeding in Cirrhosis After Cessation of Esophageal Variceal Hemorrhage by Endoscopic Therapy[J].J Clin Gastroenterol,2014,48(10):870-877.
[20]韩璞青,孙嫣.MELD、MELD-Na评分及KCH标准对妊娠期急性肝衰竭患者预后的评估价值[J].临床肝胆病杂志,2018,34(7):1508-1513.
[21]Zipprich A,Kuss O,Rogowski S,et al.Incorporating indocyanin green clearance into the Model for End Stage Liver Disease(MELD-ICG)improves prognostic accuracy in intermediate to advanced cirrhosis[J].Gut,2010,59(7):963-968.
[22]江甫柱,倪鎏达,胡峰,等.MELD-ICG对HBV/HCV肝硬化预后的评估价值[J].肝脏,2013,18(7):439-443.
[23]励夏炜.ICG排泄试验评估肝脏储备功能的进一步研究[D].浙江大学,2018.
[24]吴婧,倪鎏达,江甫柱,等.MELD-EHBF模型建立及其对ACLF预后价值[J].肝脏,2015(6):447-449,461.
收稿日期:2019-1-21;修回日期:2019-2-15
编辑/肖婷婷, 百拇医药(赵鱼扉 史政荣)
[18]張辉,贾雷,姚士伟,等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析[J].临床肝胆病杂志,2018,34(9):142-147.
[19]Wang J,Wang AJ,Li BM,et al.MELD-Na:Effective in Predicting Rebleeding in Cirrhosis After Cessation of Esophageal Variceal Hemorrhage by Endoscopic Therapy[J].J Clin Gastroenterol,2014,48(10):870-877.
[20]韩璞青,孙嫣.MELD、MELD-Na评分及KCH标准对妊娠期急性肝衰竭患者预后的评估价值[J].临床肝胆病杂志,2018,34(7):1508-1513.
[21]Zipprich A,Kuss O,Rogowski S,et al.Incorporating indocyanin green clearance into the Model for End Stage Liver Disease(MELD-ICG)improves prognostic accuracy in intermediate to advanced cirrhosis[J].Gut,2010,59(7):963-968.
[22]江甫柱,倪鎏达,胡峰,等.MELD-ICG对HBV/HCV肝硬化预后的评估价值[J].肝脏,2013,18(7):439-443.
[23]励夏炜.ICG排泄试验评估肝脏储备功能的进一步研究[D].浙江大学,2018.
[24]吴婧,倪鎏达,江甫柱,等.MELD-EHBF模型建立及其对ACLF预后价值[J].肝脏,2015(6):447-449,461.
收稿日期:2019-1-21;修回日期:2019-2-15
编辑/肖婷婷, 百拇医药(赵鱼扉 史政荣)